Spine Biologics Market by Product Type, Distribution Channel, End User 2024-2032
                     Global Spine Biologics 
Market Research and 
Forecast Report 2024-
2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved 
About IMARC Group
In ternat ional  Market  Analys is  Research and Consul t ing Group is  a leading adv iser  on management  
s t rategy and market  research wor ldwide.  We par tner  wi th c l ients  in  a l l  regions and indust ry  
vert ica ls  to  ident i fy  thei r  h ighest -value oppor tuni t ies,  address thei r  most  cr i t ica l  chal lenges,  and 
t ransform thei r  bus inesses.
IMARC’s in format ion products  inc lude major market ,  sc ient i f ic ,  economic and technological  
developments  for  bus iness leaders  in  pharmaceut ica l ,  indust r ia l ,  and h igh technology 
organizat ions.  Market  forecasts  and indust ry  analys is  for  b iotechnology,  advanced mater ia ls ,  
chemicals ,  food and beverage,  t ravel  and tour ism, nanotechnology and novel  process ing methods 
are at  the top of  the company’s  exper t ise.
IMARC’s ta i lored approach combines unfathomable ins ight  in to the dynamics o f  companies and 
markets wi th c lose cooperat ion at  a l l  levels  of  the c l ient  organizat ion.  This ensures that  our  c l ients 
achieve unmatchable compet i t ive advantage,  bui ld  more pro f ic ient  organizat ions,  and secure 
las t ing resul ts .
Accord ing  t o  t he  la t es t  repor t  by  I MARC G roup ,  t i t l ed  "Sp ine  B io log ics  Market :  
G loba l  I ndust ry  T rends ,  Share ,  S ize ,  Grow th ,  Opportun i ty  and  Forecast  2024-
2032, "  t he  g loba l  sp ine  b io l og ics  marke t  s i ze  reached  US$ 2 . 1  B i l l i on  i n  2023 .
Sp ine  b io log ics  i nc lude  va r i ous  too ls  t ha t  a re  genera l l y  used fo r  pe r f o rm ing  sp ine  
Report f us ion  su rge ry .  They  are  com mon ly  u t i l i zed  t o  t r ea t  de f o rm i t i es  t ha t  occur  due  t o  
sp ine  t rauma,  degenera t i ve  d iso rde rs ,  and  t umors .  These too l s  a re  usua l l y  
Highlight and manufac t u red  us ing  b iomate r ia l s ,  i nc lud ing  ce ramics ,  po lymers  and g lasses ,  t ha t  a re  sa fe  in  na t u re .  
They  a id  in  p romot ing  bone  g rowt h  and the  hea l i ng  p rocess  wh i le  m in im iz ing  the  
Description d is rup t i on  o f  so f t  t i s sues .  Add i t i ona l l y ,  sp ine  b io log ics  i s  cons idered  to  be  a  
p re f e r red  a l t e rna t i ve  to  sp ina l  o r t hoses  s ince  i t  r educes  the  requ i remen t  o f  
add i t i ona l  surg i ca l  p rocedures .
Request  fo r  a  PDF sample  o f  th is  repor t :  
ht tps : / / www. imarcgroup .com/sp ine-b io log ics -m arke t / reques t samp le
Report Description
G l ob a l  Sp i ne  B i o l og i cs  M a rke t  T rend s :
The  g loba l  m a r ke t  i s  p r im a r i l y  d r i ve n  by  s ign i f i can t  g r ow t h  i n  t he  he a l t hc a r e  se c t o r .  M or eov e r ,  a  co ns ide r ab le  i nc r eas e  i n  
i nves t m en t s  f r om  p r i va t e  and  pub l i c  a genc i es  ac r oss  num er o us  coun t r i es  t o  upg r ade  t he  e x i s t i n g  hea l t hca r e  
i n f r a s t r uc t u r e  i s  c r ea t i ng  a  po s i t i ve  o u t l ook  f o r  t he  m ar ke t .  A long  w i t h  t h i s ,  t h e  r i s i ng  p r eva lence  o f  ch r o n i c  and  acu t e  
sp ina l  d is o r de r s  am ong  t h e  m ass es  i s  p r ov i d ing  a  b oos t  t o  t he  m ar ke t  g r ow t h  ac r oss  t he  g lo be .  I n  l i ne  w i t h  t h i s ,  t h e  
i nc r ea s ing  ge r i a t r i c  p opu la t i on ,  wh ich  i s  m or e  susc ep t i b le  t o  m u scu lo ske le t a l  a i lm en t s ,  i s  a l so  p r o pe l l i n g  t he  m ar ke t  
g r ow t h .  
Fu r t h e r m o r e ,  c on t i n ua l  t ec hno lo g i ca l  a dvanc em e n t s  a nd  t he  i n t eg r a t i o n  o f  t h i r d - d im ens iona l  ( 3D)  im ag ing ,  r obo t i cs ,  an d  
a r t i f i c i a l  i n t e l l i g ence  ( A I )  t ec hno log ies  w i t h  sp ine  b io lo g i cs  dev i ces  t o  ass i s t  hea l t hca r e  p r o f es s iona l s  i n  pe r f o r m i ng  
com p lex  sp in e  su r ge r ies  a r e  a l so  pos i t i ve l y  i n f l uenc ing  t he  m ar ke t  g r ow t h .  Som e o f  t he  o t h e r  f ac t o r s  c on t r i bu t i n g  t o  t h e  
m ar k e t  g r ow t h  i n c lude  i nc r e as ing  hea l t hc a r e  expe nd i t u r e  and  e x t ens i ve  r ese a r ch  a nd  deve l opm en t  ( R&D )  i n  m ed ic a l  
sc ien ce .
Look i ng  f o rw ard ,  t he  mark e t  i s  an t i c i p a t ed  t o  g r ow  a t  a  CAG R o f  3 . 7%  dur i ng  t he  f o rec as t  per i o d  ( 2 024 - 2 032 ) .
V i ew  Repo r t  T O C,  F i g ures  and  T ab l e s :  h t t ps : / / w w w . i mar cgrou p . com / s p i ne - b i o l o g i cs - mar ke t
Breakup by Product:
• Spinal  A l lografts
o Machined Bones Al lograft
o Demineral ized Bone Matr ix
• Bone Graft Substitutes
o Bone Morphogenetic Proteins
o Synthetic Bone Grafts
Report 
• Cel l  Based Matr ix
Segmentation  
Breakup by Surgery Type:
• Open Spine Surgery
• Minimal ly Invasive Spine Surgery
Breakup by End User:
• Hospitals
• Ambulatory Care Centers
• Spinal  Surgery Centers
• Orthopedic Cl inics
• Others
Breakup by Region:
Report • North America
Segmentation • Asia-Pacifi c
• Europe
• Latin America
• Middle East and Afr ica
• Arthrex Inc
• Alphatec Holdings Inc.
• Exactech Inc
Competitive • Johnson & Johnson
• Medtronic plc
Landscape 
• NuVasive Inc
with Key • Orthofi x Medical Inc.
Players • Stryker Corporation
• Wright Medical  Group N.V.
• Zimmer Biomet.
How big is the global spine biologics market?
What is the expected growth rate of the global spine 
biologics market during 2024-2032?
What are the key factors driving the global spine 
biologics market?
Key 
What has been the impact of COVID-19 on the global 
Questions spine biologics market?
Answered in What is the breakup of the global spine biologics market based on the product?
the Report What is the breakup of the global spine biologics 
market based on the surgery type?
What is the breakup of the global spine biologics 
market based on the end user?
What are the key regions in the global spine biologics 
market?
Who are the key players/companies in the global spine 
biologics market?
1     P r e f a c e
2     S c o p e  a n d  M e t h o d o l o g y
    2 . 1     O b j e c t i v e s  o f  t h e  S t u d y
    2 . 2     S t a k e h o l d e r s
    2 . 3     D a t a  S o u r c e s
        2 . 3 . 1     P r i m a r y  S o u r c e s
        2 . 3 . 2     S e c o n d a r y  S o u r c e s
    2 . 4     M a r k e t  E s t i m a t i o n
Table of         2 . 4 . 1     B o t t o m - U p  A p p r o a c h        2 . 4 . 2     T o p - D o w n  A p p r o a c h    2 . 5     F o r e c a s t i n g  M e t h o d o l o g y
3     E x e c u t i v e  S u m m a r y
4     I n t r o d u c t i o n
    4 . 1     O v e r v i e w
Contents     4 . 2     K e y  I n d u s t r y  T r e n d s5     G l o b a l  S p i n e  B i o l o g i c s  M a r k e t
    5 . 1     M a r k e t  O v e r v i e w
    5 . 2     M a r k e t  P e r f o r m a n c e
    5 . 3     I m p a c t  o f  C O V I D - 1 9
    5 . 4     M a r k e t  F o r e c a s t
6      M a r k e t  B r e a k u p  b y  P r o d u c t
    6 . 1     S p i n a l  A l l o g r a f t s
        6 . 1 . 1  M a r k e t  T r e n d s
        6 . 1 . 2  K e y  S e g m e n t s
           6 . 1 . 2 . 1  M a c h i n e d  B o n e s  A l l o g r a f t
           6 . 1 . 2 . 2  D e m i n e r a l i z e d  B o n e  M a t r i x
        6 . 1 . 3  M a r k e t  F o r e c a s t
    6 . 2     B o n e  G r a f t  S u b s t i t u t e s
        6 . 2 . 1  M a r k e t  T r e n d s
        6 . 2 . 2  K e y  S e g m e n t s
           6 . 2 . 2 . 1  B o n e  M o r p h o g e n e t i c  P r o t e i n s
           6 . 2 . 2 . 2  S y n t h e t i c  B o n e  G r a f t s
       
        6 . 2 . 3  M a r k e t  F o r e c a s t
    6 . 3     C e l l  B a s e d  M a t r i x
        6 . 3 . 1  M a r k e t  T r e n d s
        6 . 3 . 2  M a r k e t  F o r e c a s t
7    M a r k e t  B r e a k u p  b y  S u r g e r y  T y p e
    7 . 1     O p e n  S p i n e  S u r g e r y
        7 . 1 . 1  M a r k e t  T r e n d s
        7 . 1 . 2  M a r k e t  F o r e c a s t
    7 . 2     M i n i m a l l y  I n v a s i v e  S p i n e  S u r g e r y
        7 . 2 . 1  M a r k e t  T r e n d s
Table of         7 . 2 . 2  M a r k e t  F o r e c a s t8    M a r k e t  B r e a k u p  b y  E n d  U s e r
    8 . 1     H o s p i t a l s
        8 . 1 . 1  M a r k e t  T r e n d s
Contents         8 . 1 . 2  M a r k e t  F o r e c a s t
    8 . 2     A m b u l a t o r y  C a r e  C e n t e r s
        8 . 2 . 1  M a r k e t  T r e n d s
        8 . 2 . 2  M a r k e t  F o r e c a s t
    8 . 3     S p i n a l  S u r g e r y  C e n t e r s
        8 . 3 . 1  M a r k e t  T r e n d s
        8 . 3 . 2  M a r k e t  F o r e c a s t
    8 . 4     O r t h o p e d i c  C l i n i c s
        8 . 4 . 1  M a r k e t  T r e n d s
        8 . 4 . 2  M a r k e t  F o r e c a s t
    8 . 5     O t h e r s
        8 . 5 . 1  M a r k e t  T r e n d s
        8 . 5 . 2  M a r k e t  F o r e c a s t
F o r  m o r e  i n f o r m a t i o n ,  v i s i t :  
ht t ps : / /w ww. i ma rc gro up . c o m /s p i ne -b i o l o g i c s -ma rke t / t o c
Disclaimer
© 2023  IMARC Al l  R ights  Reserved 
Th is  Pub l i ca t ion  and  a l l  i t ’ s  con ten ts  un less  o therw ise  men t i oned  a re  copy r i gh ted  in  the  name o f  
I n t e rna t i ona l  Marke t  Ana lys i s  Research  and  Consu l t ing  ( IMARC) .  No  pa r t  o f  t h i s  pub l i ca t ion  may  be  
rep roduced ,  repackaged ,  red i s t r i bu ted  o r  res o ld  i n  who le  o r  i n  any  pa r t .  The  pub l i ca t ion  may  a l so  
no t  be  used  i n  any  f o rm o r  by  and means  g raph i c  e lec t ron ic  o r  mechan ic a l ,  i nc lud ing  pho tocopy ing ,  
reco rd ing ,  t ap ing  o r  by  i n fo rmat i on  s to rage  o r  re t r ieva l ,  o r  by  any  o the r  f o rm,  w i t hou t  the  exp ress  
c ons en t  o f  I n t e rna t iona l  Marke t  Ana lys i s  Research  and  Consu l t i ng  ( IMARC) .
Disc la imer :  Al l  con ten ts  and  da ta  o f  t h i s  pub l i c a t i on ,  i nc lud ing  fo recas t s ,  da ta  ana lys i s  and  op in ion  
have  been  based  on  in f o rmat ion  and  sources  be l ieved  to  be  accu ra te  and  re l iab le  a t  t he  t ime  o f  
pub l i sh ing .  In t e rna t i ona l  Ma rke t  Ana l ys is  Research  and  Consu l t ing  makes  no  rep resen ta t ion  o f  
war ran t y  o f  any  k ind  as  to  t he  acc u racy  o r  comp le teness  o f  any  I n fo rmat i on  p rov ided .  IMARC 
accep ts  no  l i ab i l i t y  wha tsoever  f o r  any  los s  o r  damage  resu l t i ng  f rom op in ion ,  e r ro rs  o r  
i naccu rac ies  i f  any  f ound  th is  pub l i ca t ion .
IMARC,  IMARC Group  and  G loba l  Therapy  I ns igh t  Ser i es  a re  reg is t e red  t rademarks  o f  I n te rna t iona l  
Marke t  Ana lys i s  Research  and  Consu l t ing .  A l l  o the r  t rademarks  used  i n  th i s  pub l i ca t i on  a re  
reg i s te red  t rademarks  o f  t he i r  r espec t i ve  compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
TELEPHONE: +1-631-791-1145 
E-MAIL: [email protected]